Patients with diabetes and chronic kidney disease receiving physiologic insulin resensitization had much lower annual costs of care than similar patients not receiving it.
Richard M. Grimes, PhD
Advertisement
Articles by Richard M. Grimes, PhD
Advertisement
Latest Updated Articles
Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney DiseasePublished: January 17th 2025 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
CVS Pharmacy Completes Acquisition of Select Rite Aid Locations
2
Increased Risk of Recurrence in NSCLC Found After Preoperative PTNB
3
Accountable Care: Not Just for the Healthiest Patients
4
Novel Machine Learning Model Improves MASLD Detection in Type 2 Diabetes
5
